The Gardasil franchise is the company's second largest sales driver behind Keytruda, and Merck remains steadfast it can garner more than $11 billion from the key product in 2030. Fewer than 10% of ...

This year, pharmaceutical giant Merck (NYSE: MRK) is it: The drugmaker's shares are down by 2% in 2024 while the broader S&P 500 is up by 21%. Even when we zoom out, Merck hasn't performed ...

Derived prices are not provided by exchanges. They are derived by market makers in CFD OTC market and hence prices may not be accurate and may differ from the actual market price, meaning prices ...

Merck’s new €290m biosafety testing facility in Rockville features advanced testing capabilities. Credit: Merck/Business Wire. Germany-based Merck KGaA has announced the launch of a new €290m ($317.6m ...

Merck (MRK) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock.

Are you a print subscriber? Activate your account. By Tim Nudd - 2 hours 18 min ago By Babar Rahman - 4 hours 13 min ago By Tim Nudd - 7 hours 53 min ago By Brian Bonilla - 9 hours 12 min ago 9 ...

German pharma and technology giant Merck has announced a €5 million (£4.2m) investment in Scotland that will create further jobs at its diagnostics and blood typing facility in Livingston.

Oct 17 (Reuters) - German science and technology group Merck (MRCG.DE), opens new tab is open to more acquisitions for its Life Science business after announcing in May it would buy Mirus Bio for ...

“Our third-quarter results were strong, as we continue to make progress heading into 2025 and beyond,” said Robert M. Davis, chairman and chief executive officer, Merck. “Our pipeline is advancing and ...